2026-06600RuleSignificantWallet

Medicare Advantage Plans Get 2027 Policy and Technical Refresh

Published Date: 4/6/2026

Rule

Summary

Starting January 1, 2027, Medicare Advantage, Prescription Drug, and Cost Plan programs are getting some fresh updates! These changes improve how plans are rated, marketed, and how drugs are covered, making it easier and better for millions of Medicare users. The new rules kick in June 1, 2026, so plans can get ready to serve you smarter and smoother next year.

Analyzed Economic Effects

6 provisions identified: 6 benefits, 0 costs, 0 mixed.

Annual Part D Out‑of‑Pocket Cap Set

The rule codifies an annual out‑of‑pocket (OOP) threshold of $2,000 for CY 2025 and $2,100 for CY 2026. Going forward the OOP threshold will be increased each year by the annual percentage increase and rounded to the nearest $50.

Coverage Gap Removed; Catastrophic Cost Sharing Eliminated

The rule codifies that the Part D coverage gap and initial coverage limit were eliminated beginning in CY 2025, and that once an enrollee's incurred costs exceed the annual OOP threshold they have $0 cost sharing beginning in 2024. The Part D benefit therefore has a three‑phase structure with no coverage gap in years 2025 and later.

Insulin and Vaccine Deductible and Cap Rules

The rule codifies that the Part D deductible does not apply to ACIP‑recommended adult vaccines and covered insulin products. For CYs 2023–2025 the Part D cost‑sharing amount for a one‑month supply of covered insulin products was $35; for CY 2026 and later the applicable cost‑sharing amount is the lesser of $35, 25% of the maximum fair price (MFP), or 25% of the negotiated price.

Manufacturer Discount Program Codified

The rule codifies the Medicare Part D Manufacturer Discount Program, which began on January 1, 2025 and replaces the Coverage Gap Discount Program. Manufacturers that enter into a Manufacturer Discount Program agreement are required to provide discounts on applicable drugs in both the initial and catastrophic coverage phases.

Star Ratings Measure Set Changes

CMS is simplifying and refocusing the Star Ratings measure set and will not implement the Health Equity Index reward; instead it will continue the historical reward factor. The measure removals apply to the 2027 measurement period and the 2029 Star Ratings, with the Call Center—Foreign Language Interpreter and TTY Availability measures and the Statin Therapy for Patients with Cardiovascular Disease measure applying beginning with the 2028 Star Ratings.

SSBCI Transparency and Debit Card Rules

CMS finalizes a requirement that plan‑developed eligibility criteria for Special Supplemental Benefits for the Chronically Ill (SSBCI) must be made publicly available. CMS is also codifying and clarifying requirements for administering supplemental benefits through debit cards, with modifications and without finalizing a prohibition on marketing the dollar value of supplemental benefits.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
Rule Effective
4/6/2026
6/1/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Centers for Medicare & Medicaid Services
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register